Other Secondary Carnitine Deficiency (ICD-10-CM Code: E71.44)

Name of the Condition

• Other secondary carnitine deficiency.

Summary

Other secondary carnitine deficiency refers to a condition where carnitine levels are reduced due to external factors, such as underlying diseases, medications, or dietary issues, rather than a primary genetic defect. Carnitine is essential for fatty acid metabolism and energy production, and its deficiency can disrupt cellular processes, particularly affecting tissues like the heart and muscles. This condition may lead to systemic complications if untreated.

Causes

This disorder is caused by factors that reduce carnitine availability or increase its utilization, such as chronic kidney disease, certain medications (e.g., valproic acid), malnutrition, or metabolic stress. Unlike primary carnitine deficiency, it is not inherited but develops secondary to another condition or exposure.

Risk Factors

• Chronic kidney disease or dialysis.
• Use of medications that deplete carnitine (e.g., valproic acid).
• Malnutrition or poor dietary intake.
• Metabolic stress from illness or surgery.
• Certain genetic disorders affecting other metabolic pathways.

Symptoms

• Muscle weakness or fatigue.
• Hypotonia (reduced muscle tone).
• Cardiomyopathy (heart muscle disease).
• Recurrent hypoglycemia (low blood sugar).
• Developmental delay or regression (in severe cases).
• Metabolic crises, including hypoketotic hypoglycemia.

Diagnosis

Diagnosis involves biochemical testing to measure carnitine levels in blood or urine, often revealing deficiencies or abnormal ratios. Additional testing may include evaluating renal function, medication history, or underlying conditions contributing to carnitine loss. Genetic testing is typically not required unless a primary disorder is suspected.

Treatment Options

Treatment focuses on addressing the underlying cause, such as adjusting medications, managing kidney disease, or improving nutrition. Carnitine supplementation may be recommended to restore levels, with dosing tailored to the individual’s needs and the severity of deficiency.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and timely intervention. With appropriate treatment, symptoms may improve, but delayed or inadequate management can lead to persistent complications. Regular monitoring of carnitine levels and underlying conditions is essential for long-term management.

Complications

• Progressive muscle weakness or cardiomyopathy.
• Recurrent metabolic crises.
• Developmental delays or regression (in severe cases).
• Worsening of underlying conditions due to carnitine deficiency.

Lifestyle & Prevention

• Maintain a balanced diet with adequate protein and nutrients.
• Avoid medications known to deplete carnitine unless medically necessary.
• Manage chronic conditions (e.g., kidney disease) with regular medical care.
• Discuss supplementation with a healthcare provider if at risk of deficiency.

When to Seek Professional Help

Seek medical attention if experiencing unexplained muscle weakness, fatigue, or symptoms of hypoglycemia. Prompt evaluation is important for identifying and treating the underlying cause of carnitine deficiency.

Tips for Medical Coders

Document the underlying cause or contributing factors (e.g., chronic kidney disease, medication use) when coding for other secondary carnitine deficiency. Ensure specificity in clinical notes to support the diagnosis and justify the use of code E71.44.